Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06540079 · ClinicalTrials.gov registry record · NA
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
A NA study of Bradycardia and Atrioventricular Block, sponsored by Biotronik.
- Active
- Registry status
- NA
- Development phase
- 192
- Enrollment target
- 10
- Study locations
NCT06540079 is a NA study of Bradycardia and Atrioventricular Block that is active but no longer recruiting, run by Biotronik. The registered enrollment target is 192 participants, below the 4,406-participant average among 29 other Bradycardia trials with a reported enrollment target (96% lower). The trial reports 10 study locations across 8 states.
The verdict
NCT06540079, a NA study of Bradycardia and Atrioventricular Block, is active but no longer recruiting, sponsored by Biotronik.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia CSP S pacing lead when implanted in the left bundle branch area (LBBA). Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.
Conditions Studied
Interventions
- DEVICE Solia CSP S lead
Study Locations (10)
New York
- NYU Heart Rhythm Center - New York
- Weill Cornell Medicine - New York
Pennsylvania
- Cardiology Consultants of Philadelphia - Paoli
- Geisinger Wyoming Valley Medical Center - Wilkes-Barre
Arizona
- Banner - University Medical Center Phoenix - Phoenix
California
- Cardiology Associates Medical Group - Ventura
Florida
- Sarasota Memorial Hospital - Sarasota
Illinois
- University of Chicago - Chicago
Mississippi
- Cardiology Associates Research, LLC - Tupelo
North Carolina
- Atrium Health Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2024-12-18 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06540079
The ClinicalTrials.gov registry entry for NCT06540079 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,406-participant average among 29 other Bradycardia trials with a reported enrollment target (96% lower). The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Solia CSP S lead is the first listed.
NCT06540079 reports 10 study locations spanning 8 distinct geographic areas - top geographies include New York, Pennsylvania, Arizona.
Frequently Asked Questions
What is clinical trial NCT06540079 about?
NCT06540079 is a clinical study titled "BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S". The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia CSP S pacing lead when implanted in the left bundle branch area (LBBA). Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy w...
What is the current status of trial NCT06540079?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2024-12-18. Estimated completion is 2026-06.
What conditions does trial NCT06540079 study?
This clinical trial studies the following conditions: Bradycardia, Atrioventricular Block, Sinus Node Dysfunction.
What interventions are being tested in trial NCT06540079?
The interventions under investigation include: Solia CSP S lead (DEVICE).
Who is sponsoring clinical trial NCT06540079?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06540079 being conducted?
This trial has 10 study locations across Arizona, California, Florida, Illinois, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
RECRUITING · NA
-
Aveir DR i2i Study
ACTIVE NOT RECRUITING · NA
-
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
ACTIVE NOT RECRUITING · NA
-
EMRI SureScan™ Clinical Study
COMPLETED · NA
-
ECG Belt to Assess Electrical Synchronization
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.